PILRA antibody (N-Term)
Quick Overview for PILRA antibody (N-Term) (ABIN635597)
Target
See all PILRA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- PILRA antibody was raised against the N terminal of PILRA
-
Purification
- Affinity purified
-
Immunogen
- PILRA antibody was raised using the N terminal of PILRA corresponding to a region with amino acids IPFSFYYPWELATAPDVRISWRRGHFHRQSFYSTRPPSIHKDYVNRLFLN
-
-
-
-
Application Notes
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
PILRA Blocking Peptide, (ABIN939476), is also available for use as a blocking control in assays to test for specificity of this PILRA antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PILRA antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PILRA (Paired Immunoglobin-Like Type 2 Receptor alpha (PILRA))
-
Alternative Name
- PILRA
-
Background
- Cell signaling pathways rely on a dynamic interaction between activating and inhibiting processes. SHP-1-mediated dephosphorylation of protein tyrosine residues is central to the regulation of several cell signaling pathways. Two types of inhibitory receptor superfamily members are immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors and their non-ITIM-bearing, activating counterparts. Control of cell signaling via SHP-1 is thought to occur through a balance between PILRalpha-mediated inhibition and PILRbeta-mediated activation. This particular gene encodes the ITIM-bearing member of the receptor pair, which functions in the inhibitory role.
-
Molecular Weight
- 18 kDa (MW of target protein)
Target
-